Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

BACKGROUND AND PURPOSE: The optimal use of antiplatelet therapy for intracranial branch atheromatous disease (BAD) is not known. METHODS: We conducted a prospective multicenter, single-group trial of 144 consecutive patients diagnosed with probable BAD. All patients were treated within 12 h of sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Teruo, Tucker, Adam, Sugimura, Toshihide, Seki, Toshitaka, Fukuda, Shin, Takeuchi, Satoru, Miyata, Shiro, Fujita, Tsutomu, Hashizume, Akira, Izumi, Naoto, Kawasaki, Kazutsune, Katsuno, Makoto, Hashimoto, Masaaki, Sako, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123034/
https://www.ncbi.nlm.nih.gov/pubmed/27728903
http://dx.doi.org/10.1159/000450835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123034/
https://www.ncbi.nlm.nih.gov/pubmed/27728903
http://dx.doi.org/10.1159/000450835

Ejemplares similares